Jun 07, 2023 / 05:40PM GMT
Malgorzata Maria Kaczor Andrew - William Blair & Company L.L.C., Research Division - Partner & Research Analyst
Good afternoon, everyone. My name is Margaret Kaczor. I am the research analyst at William Blair & Company who covers Dexcom. Thank you guys for all being here. Obviously, we got 2 small rooms, so we will work on that next year.
I am required to inform you that I personally own shares of Dexcom. And beyond that, you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.
With that said, pleased to introduce Jereme Sylvain, CFO of Dexcom.
Jereme M. Sylvain - DexCom, Inc. - Executive VP, CFO & CAO
Thanks, Margaret. And thanks, everyone, for being here. Certainly excited to be back another year at the conference, a wonderful conference and a pleasure to be in front of everybody again. We want to just take a little bit of time, run through the organization, run through a little bit of background, leave a little bit of time potentially for Q&A, but really talk about
Dexcom Inc at William Blair Growth Stock Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot